NICE received one valid appeal against the FAD for this technology appraisal from Merck Sharp & Dohme Ltd. The appeal hearing is being held virtually via Zoom on Tuesday 23 June 2020 at 10am.
Appeals were also received from Action Bladder Cancer UK and Fight Bladder Cancer, however these appeals were rejected during the scrutiny stage.
This page was last updated: